Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-08-28
2007-08-28
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S596000, C564S026000, C564S048000
Reexamination Certificate
active
10616959
ABSTRACT:
The invention relates to urea- and urethane-substituted acylureas and to their physiologically tolerated salts and physiologically functional derivatives. In particular, the invention relates to the compounds of the formula Iwherein the radicals have meanings described herein, and to their physiologically tolerated salts and to processes for their preparation. The compounds are suitable for example as antidiabetics.
REFERENCES:
patent: 4665235 (1987-05-01), Brouwer et al.
patent: 6221633 (2001-04-01), Ertl et al.
patent: 6221897 (2001-04-01), Frick et al.
patent: 6245744 (2001-06-01), Frick et al.
patent: 6342512 (2002-01-01), Kirsch et al.
patent: 10142734 (2003-03-01), None
patent: 0 166 729 (1984-08-01), None
patent: 116729 (1984-08-01), None
patent: 0 167 197 (1986-08-01), None
patent: 0 221 847 (1987-05-01), None
patent: 0462884 (1991-12-01), None
patent: 01034953 (1989-06-01), None
patent: WO97/26265 (1997-07-01), None
patent: WO97/41097 (1997-11-01), None
patent: WO98/08871 (1998-03-01), None
patent: WO99/03861 (1999-01-01), None
patent: WO99/15525 (1999-04-01), None
patent: WO 00/40569 (2000-07-01), None
patent: WO 00/63208 (2000-10-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO 00/66585 (2000-11-01), None
patent: WO 00/71549 (2000-11-01), None
patent: WO 00/78312 (2000-12-01), None
patent: WO 01/09111 (2001-02-01), None
patent: WO 01/83451 (2001-11-01), None
patent: WO 01/85695 (2001-11-01), None
patent: 01/94300 (2001-12-01), None
patent: WO 01/91752 (2001-12-01), None
patent: 02/096864 (2002-12-01), None
A. Asakawa et al., “Cocaine-Amphetamine-Regulated Transcript Influences Energy Metabolism, Anxiety and Gastric Emptying in Mice”, Horm. Metab. Res., 2001, pp. 554-558, vol. 33.
P. Drueckes et al., “Photometric Microtiter Assay of Inorganic Phosphate in the Presence of Acid-Labile Organic Phosphates”, Analytical Biochemistry, 1995, p. 173-177, vol. 230.
H.D. Engers et al., “Kinetic mechanism of phosphorylase a. I. Initial velocity studies”, Department of Biochemistry, University of Alberta, Edmonston 7, Alberta, Jan. 12, 1970, pp. 746-754.
Daniel W. Lee et al., “Leptin agonists as a potential approach to the treatment of obesity”, Drugs of the Future, 2001, pp. 873-881, vol. 26, No. 9.
Hiroshi Okada et al., “Synthesis and Antitumor Activities of Prodrugs of Benzoylphenylureas”, Chem. Pharm. Bull., 1994, pp. 57-61, vol. 42, No. 1.
Javier Salvador et al., “Perspectives in the therapeutic use of leptin”, Expert Opin. Pharmacother, 2001, 2001, pp. 1615-1622, vol. 2, No. 10.
Pravenn Tyle, “Iontophoretic Devices for Drug Delivery”, Pharmaceutical Research, 1986, pp. 318-326, vol. 3, No. 6.
H.J.F. Zunft et al., “Carob Pulp Preparation for Treatment of Hypercholesterolemia”, Advances In Natural Therapy, Sep./Oct. 2001, pp. 231-236, vol. 18, No. 5.
Burger Hans-Joerg
Defossa Elisabeth
Herling Andreas
Kadereit Dieter
Klabunde Thomas
Davis Zinna N.
Kurys Barbara E.
Sanofi-Aventis Deutschland GmbH
LandOfFree
Urea- and urethane-substituted acylureas, process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea- and urethane-substituted acylureas, process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea- and urethane-substituted acylureas, process for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865627